GlycoMimetics Stock (NASDAQ: GLYC) stock price, news, charts, stock research, profile.
Open | $3.070 |
Close | - |
Volume / Avg. | 115.627K / 345.015K |
Day Range | 2.900 - 3.110 |
52 Wk Range | 1.110 - 3.530 |
Market Cap | $190.605M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 3.18% |
Days to Cover | 4.46 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of GlycoMimetics (NASDAQ: GLYC) through any online brokerage.
Other companies in GlycoMimetics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Atossa Therapeutics (NASDAQ:ATOS), Adicet Bio (NASDAQ:ACET) and Agenus (NASDAQ:AGEN).
The latest price target for GlycoMimetics (NASDAQ: GLYC) was reported by HC Wainwright & Co. on Wednesday, March 27, 2024. The analyst firm set a price target for 8.00 expecting GLYC to rise to within 12 months (a possible 170.27% upside). 6 analyst firms have reported ratings in the last year.
The stock price for GlycoMimetics (NASDAQ: GLYC) is $2.96 last updated Today at March 28, 2024 at 10:15 AM EDT.
There are no upcoming dividends for GlycoMimetics.
GlycoMimetics’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for GlycoMimetics.
GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.